Importantly, our analysis also confirmed several well-characterized shared neoantigens, including AVEEVSLRK derived from an NPM1 frameshift mutation in AML, SLMEQIPHL from a CKAP2 frameshift mutation in colon cancer, and 37 private neoantigens now deposited in the IEDB database. This evidence concerns the gene CKAP2 and acute myeloid leukemia.